Outcomes of Fecal Diversion in Perianal Crohn's Disease: A Systematic Review and Meta-Analysis

Abstract

Objectives: Perianal fistulizing Crohn's disease (pfCD) is a severe type of inflammatory bowel disease resulting in significant patient morbidity. Despite advancements in treatments, pfCD remains challenging to manage with low healing rates. Fecal diversion (FD) has previously demonstrated clinical improvement for patients with refractory disease. Our meta-analysis aimed to explore the clinical response to FD, rates of successful restoration of bowel continuity after FD, rates of re-diversion, and factors affecting the success of FD in pfCD.

Methods: A systematic review and meta-analysis was carried out of adult patients who had undergone FD for pfCD, with detailed patient outcome data. Studies were identified through a literature search of six bibliographic databases and one trial register, all run on February 28, 2025, including MEDLINE ALL, EMBASE, Emcare, APA PsycInfo, CINAHL, Cochrane Library, and Clinicaltrials.gov.

Results: Seventeen studies encompassing 714 adult pfCD patients were included. FD resulted in a 65% clinical improvement rate, yet considerable heterogeneity existed in study methodologies and outcome definitions. While 29% of patients achieved bowel restoration within a median follow-up of 58.2 months, challenges in sustaining the effects were evident, with 10% requiring repeat diversion and a 37% overall proctectomy/proctocolectomy rate. Factors associated with diversion success included the absence of rectal involvement and quiescent luminal disease, with biologic use showing no impact on outcomes.

Conclusions: FD offers symptom control in pfCD, although restoration rates remain low. These findings emphasize the need for individualized patient counseling. Future research should strive for uniform measures and refined approaches to enhance pfCD management.

Keywords

fecal diversion / inflammatory bowel diseases / perianal fistulizing Crohn's disease

References

[1] D. A. Schwartz, E. V. Loftus,, W. J. Tremaine, et al., “The Natural History of Fistulizing Crohn's Disease in Olmsted County, Minnesota,” Gastroenterology 122, no. 4 (2002): 875-880.

[2] A. Spinelli, H. Yanai, P. Girardi, et al., “The Impact of Crohn's Perianal Fistula on Quality of Life: Results of an International Patient Survey,” Crohn's & Colitis 360 5, no. 3 (2023): otad036, https://doi.org/10.1093/crocol/otad036.

[3] I. Molendijk, V. J. A. A. Nuij, A. E. van der Meulen-de Jong, and C. J. van der Woude, “Disappointing Durable Remission Rates in Complex Crohn's Disease Fistula,” Inflammatory Bowel Diseases 20, no. 11 (2014): 2022-2028.

[4] P. H. Harper, E. C. Lee, M. G. Kettlewell, M. K. Bennett, and D. P. Jewell, “Role of the Faecal Stream in the Maintenance of Crohn's Colitis,” Gut 26, no. 3 (1985): 279-284.

[5] R. Mennigen, B. Heptner, N. Senninger, and E. Rijcken, “Temporary Fecal Diversion in the Management of Colorectal and Perianal Crohn's Disease,” Gastroenterology Research and Practice 2015 (2015): 286315, https://doi.org/10.1155/2015/286315.

[6] J. D. McCurdy, J. Reid, R. Yanofsky, et al., “Fecal Diversion for Perianal Crohn Disease in the Era of Biologic Therapies: A Multicenter Study,” Inflammatory Bowel Diseases 28, no. 2 (2022): 226-233.

[7] M. J. Lee, N. Heywood, P. M. Sagar, S. R. Brown, and N. S. Fearnhead, “Surgical Management of Fistulating Perianal Crohn's Disease: A UK Survey,” Colorectal Disease 19, no. 3 (2017): 266-273.

[8] S. Singh, N. S. Ding, K. L. Mathis, et al., “Systematic Review with Meta-Analysis: Faecal Diversion for Management of Perianal Crohn's Disease,” Alimentary Pharmacology & Therapeutics 42, no. 7 (2015): 782-792.

[9] M. J. Page, J. E. McKenzie, P. M. Bossuyt, et al., “The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews,” BMJ 372 (2021): n71, https://doi.org/10.1136/bmj.n71.

[10] National Institute for Health and Care Research, “PROSPERO Database [Internet],”https://www.crd.york.ac.uk/PROSPERO/.

[11] H. K. Grossetta Nardini and L. Wang, The Yale MeSH Analyzer [Internet] (Cushing/Whitney Medical Library, 2017), https://mesh.med.yale.edu/.

[12] J. Koster, “PubMed PubReMiner,”2007 Version 1.2, https://hgserver2.amc.nl/cgi-bin/miner/miner2.cgi.

[13] J. M. Clark, S. Sanders, M. Carter, et al., “Improving the Translation of Search Strategies Using the Polyglot Search Translator: A Randomized Controlled Trial,” Journal of the Medical Library Association 108, no. 2 (2020): 195-207.

[14] G. A. Wells, B. Shea, D. O'Connell, et al., The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses (Ottawa Hospital Research Institute, 2021), https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.

[15] D. R. Grant, Z. Cohen, and R. S. McLeod, “Loop Ileostomy for Anorectal Crohn's Disease,” Canadian Journal of Surgery 29, no. 1 (1986): 32-35.

[16] M. C. Winslet, H. Andrews, R. N. Allan, and M. R. Keighley, “Fecal Diversion in the Management of Crohn's Disease of the Colon,” Diseases of the Colon & Rectum 36, no. 8 (1993): 757-762.

[17] K. L. Rehg, J. E. Sanchez, B. R. Krieger, and J. E. Marcet, “Fecal Diversion in Perirectal Fistulizing Crohn's Disease Is an Underutilized and Potentially Temporary Means of Successful Treatment,” American Surgeon 75, no. 8 (2009): 715-718.

[18] C. M. Edwards, B. D. George, D. P. Jewell, B. F. Warren, N. J. Mortensen, and M. G. Kettlewell, “Role of a Defunctioning Stoma in the Management of Large Bowel Crohn's Disease,” British Journal of Surgery 87, no. 8 (2000): 1063-1066.

[19] T. Yamamoto, R. N. Allan, and M. R. Keighley, “Effect of Fecal Diversion Alone on Perianal Crohn's Disease,” World Journal of Surgery 24, no. 10 (2000): 1258-1263.

[20] J. M. Régimbeau, Y. Panis, L. Cazaban, et al., “Long-Term Results of Faecal Diversion for Refractory Perianal Crohn's Disease,” Colorectal Disease 3, no. 4 (2001): 232-237.

[21] M. K. H. Hong, A. Craig Lynch, S. Bell, et al., “Faecal Diversion in the Management of Perianal Crohn's Disease,” Colorectal Disease 13, no. 2 (2011): 171-176.

[22] J. Sauk, D. Nguyen, V. Yajnik, et al., “Natural History of Perianal Crohn's Disease After Fecal Diversion,” Inflammatory Bowel Diseases 20, no. 12 (2014): 2260-2265.

[23] J. Gu, M. A. Valente, F. H. Remzi, and L. Stocchi, “Factors Affecting the Fate of Faecal Diversion in Patients With Perianal Crohn's Disease,” Colorectal Disease 17, no. 1 (2015): 66-72.

[24] E. Hain, L. Maggiori, M. Orville, X. Tréton, Y. Bouhnik, and Y. Panis, “Diverting Stoma for Refractory Ano-perineal Crohn's Disease: Is It Really Useful in the Anti-TNF Era? A Multivariate Analysis in 74 Consecutive Patients,” Journal of Crohn's and Colitis 13, no. 5 (2019): 572-577.

[25] A. L. Lightner, H. Buhulaigah, K. Zaghiyan, et al., “Is Intestinal Diversion an Effective Treatment for Distal Crohn's Disease?,” Inflammatory Bowel Diseases 28, no. 4 (2022): 547-552.

[26] G. Kassim, C. Yzet, N. Nair, et al., “Long-Term Outcomes of the Excluded Rectum in Crohn's Disease: A Multicenter International Study,” Inflammatory Bowel Diseases 29, no. 3 (2023): 417-422.

[27] B. Alliet, G. Bislenghi, S. Vermeire, et al., “‘Temporary’ Faecal Diversion in Refractory Crohn's Disease: Too Good to Be True? A Retrospective, Single Centre Analysis,” Journal of Crohn's and Colitis 19, no. Suppl 1 (2025): i1581.

[28] M. A. J. Becker, A. J. M. Pronk, K. Gecse, R. Hompes, W. A. Bemelman, and C. J. Buskens, “Long-Term Outcomes of ‘Temporary’ Defunctioning in Patients With Severe Perianal Crohn's Disease,” Colorectal Disease 27, no. 2 (2025): e17289, https://doi.org/10.1111/codi.17289.

[29] P. H. Harper, M. G. Kettlewell, and E. C. Lee, “The Effect of Split Ileostomy on Perianal Crohn's Disease,” British Journal of Surgery 69, no. 10 (1982): 608-610.

[30] E. Anand, J. Devi, D. H. Ballard, et al., “Defining Radiological Healing in Perianal Fistulizing Crohn's Disease: A TOpClass Global Expert Delphi Consensus,” Clinical Gastroenterology and Hepatology (2025), https://doi.org/10.1016/j.cgh.2025.02.009.

[31] B. Caron, F. D'Amico, S. Danese, and L. Peyrin-Biroulet, “Endpoints for Perianal Crohn's Disease Trials: Past, Present and Future,” Journal of Crohn's and Colitis 15, no. 8 (2021): 1387-1398.

RIGHTS & PERMISSIONS

2025 The Author(s). Journal of Digestive Diseases published by Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.